Paper Details
- Home
- Paper Details
The effectiveness of cerebrolysin, a multi-modal neurotrophic factor, for treatment of post-covid-19 persistent olfactory, gustatory and trigeminal chemosensory dysfunctions: a randomized clinical trial.
Author: AhmedMohamed Azzam Abdel-Razek, HamedSherifa Ahmed
Original Abstract of the Article :
BACKGROUND: This trial aimed to monitor the outcomes of persistent post-covid-19 smell and taste disorders after cerebrolysin therapy, a NTF, and olfactory and gustatory trainings. RESEARCH DESIGN AND METHODS: This was a prospective randomized trial. It included 250 patients (male = 93, female = 15...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/17512433.2023.2282715
データ提供:米国国立医学図書館(NLM)
Cerebrolysin: A Potential Treatment for Post-COVID-19 Chemosensory Dysfunctions
This study explores the field of neurology, focusing on the effectiveness of cerebrolysin, a neurotrophic factor, in treating persistent post-COVID-19 olfactory, gustatory, and trigeminal chemosensory dysfunctions. Researchers conducted a randomized clinical trial involving 250 patients with these persistent chemosensory disorders, evaluating the outcomes of cerebrolysin therapy, olfactory and gustatory training, and a control group.
Cerebrolysin: Promising Results for Post-COVID-19 Chemosensory Disorders
The researchers found that cerebrolysin treatment demonstrated a fast, promising, and consistent effect, with a cure rate exceeding 60%. The study concluded that cerebrolysin's neurotrophic properties, which stimulate and enhance neuronal regeneration, could be responsible for its effectiveness in treating these persistent chemosensory disorders. Further research is needed to confirm these findings and explore the long-term effects of cerebrolysin therapy.
Managing Post-COVID-19 Chemosensory Dysfunctions
This research offers a glimmer of hope for individuals experiencing persistent chemosensory dysfunctions after COVID-19 infection. The findings suggest that cerebrolysin therapy, combined with olfactory and gustatory training, could be a valuable treatment option. It's essential to consult with a healthcare professional to discuss appropriate diagnosis and treatment options, as well as potential side effects of cerebrolysin therapy.
Dr.Camel's Conclusion
Just as a camel's keen sense of smell guides it through the vast desert, the ability to taste and smell is essential for a fulfilling life. This research offers a promising avenue for treating persistent chemosensory disorders following COVID-19, providing hope for restoring these vital senses.
Date :
- Date Completed n.d.
- Date Revised 2023-12-09
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.